Trade Mark Journal No.2026/030 24 July 2026
WO0000001927204 (5,44)
Office of origin: United States of America
Date of International Registration:12 June 2026
Date of designation in the UK:
12 June 2026

International priority date claimed: 15 December 2025
(United States of America)
(99548579)
- Class 5
- Pharmaceutical preparations for the treatment of neurological disorders.
- Class 44
- Providing medical information via a website; providing healthcare information.
XENON PHARMACEUTICALS INC.
Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA